✦ LIBER ✦

Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial

✍ Scribed by Alfons JM van den Eertwegh; Jurjen Versluis; H Pieter van den Berg; Saskia JAM Santegoets; R Jeroen A van Moorselaar; Tim M van der Sluis; Helen E Gall; Thomas C Harding; Karin Jooss; Israel Lowy; Herbert M Pinedo; Rik J Scheper; Anita GM Stam; B Mary E von Blomberg; Tanja D de Gruijl; Kristen Hege; Natalie Sacks; Winald R Gerritsen

Book ID: 117785949
Publisher: The Lancet
Year: 2012
Tongue: English
Weight: 306 KB
Volume: 13
Category: Article
ISSN: 1470-2045
DOI: 10.1016/s1470-2045(12)70007-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Beneficial impact of peripheral blood pr

Beneficial impact of peripheral blood progenitor cells in patients with metastatic breast cancer treated with high-dose chemotherapy plus granulocyte-macrophage colony-stimulating factor a randomized trial

✍ Alan Kritz; John P. Crown; Robert J. Motzer; Lilian M. Reich; Glenn Heller; Mich 📂 Article 📅 1993 🏛 John Wiley and Sons 🌐 English ⚖ 672 KB

Phase I rapid dose-escalation study of A

Phase I rapid dose-escalation study of AGS-1C4D4, a human anti-PSCA (prostate stem cell antigen) monoclonal antibody, in patients with castration-resistant prostate cancer: a PCCTC trial

✍ Emmanuel S. Antonarakis; Michael A. Carducci; Mario A. Eisenberger; Samuel R. De 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 316 KB